Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Böhle

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Urology|August 13, 2003
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancerAndreas Böhle, Sven Brandau
European Urology|June 21, 2002
Molecular aspects of bladder cancer IV: gene therapy of bladder cancerPeter Ardelt, Andreas Böhle
Current Urology Reports|January 23, 2003
Antisense oligonucleotide therapy for urologic tumorsIngo Kausch, Andreas Böhle
The Journal of Urology|August 12, 2005
Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancerCarsten Philipp Brocks, Hartwig Büttner, Andreas Böhle
Urological Research|August 31, 2002
The role of LFA-1 in the lysis of bladder cancer cells by bacillus Calmette-Guérin and interleukin 2-activated killer cellsHenrik Suttmann, Dieter Jocham, Andreas Böhle, et al.
Infection and Immunity|July 23, 2003
Stimulation of neutrophil granulocytes with Mycobacterium bovis bacillus Calmette-Guérin induces changes in phenotype and gene expression and inhibits spontaneous apoptosisHenrik Suttmann, Nadine Lehan, Andreas Böhle, et al.
Oncology Reports|August 4, 2004
Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladderStefan Krüger, Frank Noack, Andreas Böhle, et al.
International Journal of Oncology|June 7, 2003
Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladderStefan Krüger, Franziska Mess, Andreas Böhle, et al.
Current Urology Reports|June 27, 2002
Immune gene therapy in urologyIngo Kausch, Peter Ardelt, Andreas Böhle, et al.
Cancer Gene Therapy|September 12, 2002
In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154Angelica Loskog, Thomas H Tötterman, Andreas Böhle, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Urology|August 13, 2003
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancerAndreas Böhle, Sven Brandau
European Urology|June 21, 2002
Molecular aspects of bladder cancer IV: gene therapy of bladder cancerPeter Ardelt, Andreas Böhle
Current Urology Reports|January 23, 2003
Antisense oligonucleotide therapy for urologic tumorsIngo Kausch, Andreas Böhle
The Journal of Urology|August 12, 2005
Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancerCarsten Philipp Brocks, Hartwig Büttner, Andreas Böhle
Urological Research|August 31, 2002
The role of LFA-1 in the lysis of bladder cancer cells by bacillus Calmette-Guérin and interleukin 2-activated killer cellsHenrik Suttmann, Dieter Jocham, Andreas Böhle, et al.
Infection and Immunity|July 23, 2003
Stimulation of neutrophil granulocytes with Mycobacterium bovis bacillus Calmette-Guérin induces changes in phenotype and gene expression and inhibits spontaneous apoptosisHenrik Suttmann, Nadine Lehan, Andreas Böhle, et al.
Oncology Reports|August 4, 2004
Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladderStefan Krüger, Frank Noack, Andreas Böhle, et al.
International Journal of Oncology|June 7, 2003
Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladderStefan Krüger, Franziska Mess, Andreas Böhle, et al.
Current Urology Reports|June 27, 2002
Immune gene therapy in urologyIngo Kausch, Peter Ardelt, Andreas Böhle, et al.
Cancer Gene Therapy|September 12, 2002
In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154Angelica Loskog, Thomas H Tötterman, Andreas Böhle, et al.
Pageof 4